...
首页> 外文期刊>In vivo. >Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
【24h】

Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.

机译:恶性黑色素瘤中基质金属蛋白酶的表达:侵袭和转移中的肿瘤-细胞外基质相互作用。

获取原文
获取原文并翻译 | 示例

摘要

Structural changes in the extracellular matrix (ECM) are necessary for cell migration during tissue remodeling and tumor invasion. The matrix metalloproteinases (MMPs) and their inhibitors have been shown to be critical modulators of ECM composition and are, thus, crucial in neoplastic cell invasion and metastasis. Expression of MMP-2, -3, -9, -10, and -13 was investigated in human malignant melanomas (MMs) employing an indirect alkaline phosphatase conjugated immunocytochemical technique. Evaluation of the results was based on (a) the percent of neoplastically transformed cells/surrounding stroma that reacted positively and (b) a measure of staining intensity [graded from A (highest) to D]. The two forms of stromelysin, MMP-3 and -10, share 82% sequence homology, but exhibit differences in cellular synthesis and inducibility by cytokines and growth factors in vitro. Strong overall expression of MMP-3 and -10 was found in MMs, especially in the ECM adjacent to blood vessels. Positive immunoreactivity could be seen for these two MMPs in the ECM surrounding over 90% of the neoplastically transformed cells (++++), and the staining intensity was also the strongest possible (A,B). Focal (+), high intensity (A,B) staining could be detected for MMP-2, -9, and -13. Thus, it seems that the stromelysins are involved in the generalized growth and expansion of the neoplastic cell mass, while MMP-2, -9 and -13 are involved in the neoangiogenic and focal clonal selection and expansion phenomena associated with in situ tumor progression, invasion of the microvasculature, and metastasis.
机译:细胞外基质(ECM)的结构变化对于组织重塑和肿瘤侵袭期间的细胞迁移是必需的。基质金属蛋白酶(MMPs)及其抑制剂已被证明是ECM组成的关键调节剂,因此在肿瘤细胞的侵袭和转移中起关键作用。使用间接碱性磷酸酶偶联的免疫细胞化学技术研究了人恶性黑色素瘤(MM)中MMP-2,-3,-9,-10和-13的表达。结果的评估基于(a)呈阳性反应的赘生性转化细胞/周围基质的百分比,以及(b)染色强度的度量[从A(最高)到D]。基质溶菌素的两种形式,MMP-3和-10,具有82%的序列同源性,但在细胞合成和细胞因子和生长因子的体外诱导性方面表现出差异。在MM中,特别是在与血管相邻的ECM中,发现了MMP-3和-10的强总体表达。在90%以上的肿瘤转化细胞(++++)中,ECM中的这两个MMP都可以看到阳性免疫反应,并且染色强度也可能是最强的(A,B)。可以检测到MMP-2,-9和-13的局灶性(+),高强度(A,B)染色。因此,似乎溶菌素参与了肿瘤细胞团的普遍生长和扩增,而MMP-2,-9和-13参与了与原位肿瘤进展相关的新血管生成和局灶性克隆选择和扩增现象,微血管的浸润和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号